Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Nutr Metab Cardiovasc Dis ; 24(4): 428-33, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24370448

RESUMEN

BACKGROUND AND AIMS: Omega-3 fatty acids suppress Thromboxane A(2) (TxA(2)) generation via mechanisms independent to that of aspirin therapy. We sought to evaluate whether baseline omega-3 fatty acid levels influence arachidonic acid proven platelet-cyclooxygenase-1 (COX-1) independent TxA(2) generation (TxA(2) generation despite adequate aspirin use). METHODS AND RESULTS: Subjects with acute myocardial infarction, stable CVD or at high risk for CVD, on adequate aspirin therapy were included in this study. Adequate aspirin action was defined as complete inhibition of platelet-COX-1 activity as assessed by <10% change in light transmission aggregometry to ≥1 mmol/L arachidonic acid. TxA(2) production was measured via liquid chromatography-tandem mass spectrometry for the stable TxA(2) metabolite 11-dehydro-thromboxane B2 (UTxB2) in urine. The relationship between baseline fatty acids, demographics and UTxB(2) were evaluated. Baseline omega-3 fatty acid levels were not associated with UTxB(2) concentration. However, smoking was associated with UTxB(2) in this study. CONCLUSION: Baseline omega-3 fatty acid levels do not influence TxA(2) generation in patients with or at high risk for CVD receiving adequate aspirin therapy. The association of smoking and TxA(2) generation, in the absence of platelet COX-1 activity, among aspirin treated patients warrants further study.


Asunto(s)
Aspirina/uso terapéutico , Plaquetas/efectos de los fármacos , Enfermedades Cardiovasculares/tratamiento farmacológico , Ciclooxigenasa 1/sangre , Inhibidores de la Ciclooxigenasa/uso terapéutico , Ácidos Grasos Omega-3/sangre , Tromboxano A2/sangre , Anciano , Biomarcadores/sangre , Biomarcadores/orina , Plaquetas/enzimología , Enfermedades Cardiovasculares/sangre , Enfermedades Cardiovasculares/enzimología , Cromatografía Liquida , Femenino , Humanos , Masculino , Persona de Mediana Edad , Agregación Plaquetaria/efectos de los fármacos , Pruebas de Función Plaquetaria , Fumar/efectos adversos , Fumar/sangre , Fumar/orina , Espectrometría de Masas en Tándem , Tromboxano B2/análogos & derivados , Tromboxano B2/orina
2.
J Immunol ; 160(9): 4418-26, 1998 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-9574546

RESUMEN

We previously reported that the AUG-burdened 5' untranslated region (UTR) of IL-15 mRNA impedes its translation. Here we demonstrate that the nucleotide or protein sequences of the IL-15 signal peptide and carboxyl terminus also contribute to the poor translation of IL-15 transcripts. In particular, the exchange of the IL-15 signal peptide coding sequence with that of IL-2 increased cellular and secreted levels of IL-15 protein 15- to 20-fold in COS cells, while IL-2 transcripts with the IL-15 signal peptide generated 30- to 50-fold less IL-2 protein than wild-type IL-2. Furthermore, the addition of an artificial epitope tag to the 3' coding sequence of IL-15 increased its protein production 5- to 10-fold. Combining these two IL-15 message modifications, in addition to removing the 5' UTR, increased IL-15 synthesis 250-fold compared with a wild-type construct with an intact 5' UTR. These data suggest that IL-15 mRNA, unlike IL-2 mRNA, may exist in translationally inactive pools. By storing translationally quiescent IL-15 mRNA, cells might respond to intracellular infections or other stimuli by rapidly transforming IL-15 message into one that can be efficiently translated.


Asunto(s)
Interleucina-15/biosíntesis , Interleucina-15/genética , Biosíntesis de Proteínas , Animales , Células COS , ARN Mensajero/análisis , ARN Mensajero/genética , Análisis de Secuencia , Transfección
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...